Relevance of the Immunoglobulin V-H somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens

Katherine I Lin, Constantine S Tam, Michael J Keating, William G Wierda, Susan O'Brien, Susan Lerner, Kevin R Coombes, Ellen Schlette, Alessandra Ferrajoli, Lynn L Barron, Thomas J Kipps, Laura Rassenti, Stefan Faderl, Hagop Kantarjian, Lynne V Abruzzo